NEFL and early-onset autosomal dominant Alzheimer disease: By focusing on NfL as a biomarker for neurodegenerative decline, most of the scientific literature investigated its potential role in the onset, progression, and prognosis of most neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis) [31-34].